Received Nov 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | N/A | z006889 | IM / LA |
patient received capvaxive on 10/25/25, 5 days later on 10/30/25 at around 3 in the afternoon she developed cellulitis for which she sought treatment from her physician on 10/31/25. She was treated with an antibiotic (she reported a zpak, but her profile shows bactrim DS for 7 days). she reports treatment was successful.
none
asthma
loratadine, multi-vitamin, furosemide, potassium chloride, losartan
none
unkown.